Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
Mohamed A Mekky,1 Hani I Sayed,2 Mohamed O Abdelmalek,1 Medhat A Saleh,3 Osman A Osman,1 Heba A Osman,4 Khairy H Morsy,5 Helal F Hetta6,7 1Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut, Egypt; 2Center for Management of Viral Hepatitis, Ministry of Health, A...
Main Authors: | Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, Osman HA, Morsy KH, Hetta HF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/prevalence-and-predictors-of-occult-hepatitis-c-virus-infection-among--peer-reviewed-article-IDR |
Similar Items
-
Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
by: Inas E L-Khedr Mohamed, et al.
Published: (2021-04-01) -
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
by: Maha M Elsabaawy, et al.
Published: (2019-01-01) -
The Efficacy of Generic Daclatasvir-Sofosbuvir as Pan-Genotypic Regiment for Hepatitis C Virus (HCV) Infected Patients in Bandung Indonesia
by: Muhammad Begawan Bestari, et al.
Published: (2020-07-01) -
The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV
by: Mohamed AbdElrahman, et al.
Published: (2023-01-01) -
Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy
by: Jacob A. Langness, et al.
Published: (2017-05-01)